Signaling pathways
-
BA8725 PI3K-IN-22Summary: PI3K-IN-22 is a dual kinase inhibitor. - BA8726 FT-1518Summary: FT-1518 is a selective, orally available, potent next generation and inhibitor.
- BA8728 PS210Summary: PS210 is a potent and selective activator of the targeted PIF-binding pocket.
- BA8729 PDK1-IN-RS2Summary: PDK1-IN-RS2 is a peptide docking motif (PIFtide) analog.
- BA8730 PS47Summary: PS47 is the inactive E-isomer of PS48.
- BA8731 BX-320Summary: BX-320 is a selective, ATP-competitive, orally effective direct inhibitor.
-
BA8732 UCL-TRO-1938Summary: UCL-TRO-1938 is a potent denatured activator with a value of approximately 60 μM. - BA8733 STX-478Summary: STX-478 is an orally effective, blood-brain barrier permeable, mutation-selective mutational inhibitor.
- BA8734 RLY-2608Summary: An inhibitor.
- BA8735 CNX-1351Summary: CNX-1351 is a potent and selective inhibitor.